The new clinical domain concerns hybrid chains. These synthetic entities merge segments derived from various protein sources, facilitating the creation of distinct therapeutic functions. This approach presents the https://chimerapeptides007865.wiki-cms.com/8856977/chimera_peptides_a_novel_therapeutic_frontier